Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR ...

Researchers have successfully developed a supercharged iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the cells, particularly against cancer cells that are harder ...

Scientists have supercharged CAR-T therapy, making it more powerful against elusive cancer cells that usually escape ...

Scientists may have unlocked a new milestone in cancer treatment. An individual who received CAR T-cell therapy has been in ...

The long-term survival of a patient with neuroblastoma suggests the personalized cancer treatment may work for solid tumors, not just blood cancers.

Investigators detected low levels of CAR T cells persisting in patients during the follow-up observation period, with higher persistence detected in long-term survivors. The first-generation CAR T ...

Allogene Therapeutics is undervalued. Read more on ALLO stock's cash runway, innovative CAR-T therapies, and market expansion with potential breakthroughs.

Although chimeric antigen receptor T-cell therapy has raised hopes for long-term remission in autoimmune disease, it has ...

The "Chimeric Antigen Receptor T-Cell Therapy (CAR-T) - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. The Chimeric Antigen Receptor T-Cell Therapy (CAR-T) ...

A handful of biotechs are asking a next-generation question ... body [to make] literal homeostatic space for the incoming CAR-T cells,” Kevin Friedman, CEO of Kelonia Therapeutics, told ...

Laboratories International announced an agreement with Singapore General Hospital SGH to provide Current Good Manufacturing ...

IN8bio (INAB) unveiled INB-600, its next generation gammadelta T cell-based TCE platform. It is designed to address one of the biggest ...